Your browser doesn't support javascript.
loading
A case of relapsing and refractory catastrophic anti-phospholipid syndrome successfully managed with eculizumab, a complement 5 inhibitor.
Wig, Surabhi; Chan, Marian; Thachil, Jecko; Bruce, Ian; Barnes, Theresa.
Afiliación
  • Wig S; The Kellgren Centre for Rheumatology, Central Manchester University Hospitals NHS Foundation Trust, Manchester Royal Infirmary, Manchester.
  • Chan M; Department of Rheumatology, Countess of Chester Hospital NHS Foundation Trust, Chester.
  • Thachil J; Department of Haematology, Central Manchester University Hospitals NHS Foundation Trust, Manchester Royal Infirmary.
  • Bruce I; The Kellgren Centre for Rheumatology, Central Manchester University Hospitals NHS Foundation Trust, Manchester Royal Infirmary, Manchester, Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, The University of Manchester, Manchest
  • Barnes T; Department of Rheumatology, Countess of Chester Hospital NHS Foundation Trust, Chester.
Rheumatology (Oxford) ; 55(2): 382-4, 2016 Feb.
Article en En | MEDLINE | ID: mdl-26472567
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Complemento C5 / Síndrome Antifosfolípido / Anticuerpos Monoclonales Humanizados Tipo de estudio: Diagnostic_studies Límite: Adult / Female / Humans Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2016 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Complemento C5 / Síndrome Antifosfolípido / Anticuerpos Monoclonales Humanizados Tipo de estudio: Diagnostic_studies Límite: Adult / Female / Humans Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2016 Tipo del documento: Article